Is renal Na(+),K(+)-ATPase a new target for renin–angiotensin blocking agents in diabetic nephropathy?

Por Rossing, Peter
Publicado em 2008

Mineralocorticoid Receptor Antagonists for Diabetic Kidney Disease

Por Rossing, Peter
Publicado no Clin J Am Soc Nephrol (2020)

Can ADAMTS13 Lead Us to the Paradise of Personalized Medicine?

Por Rossing, Peter, Lajer, Maria
Publicado em 2013

Diagnosis of diabetic kidney disease: state of the art and future perspective

Por Persson, Frederik, Rossing, Peter
Publicado no Kidney Int Suppl (2011) (2018)

Direct renin inhibition in chronic kidney disease

Por Persson, Frederik, Rossing, Peter, Parving, Hans-Henrik
Publicado em 2013

Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease

Por Persson, Frederik, Frimodt-Møller, Marie, Rossing, Peter
Publicado no Kidney Int Rep (2019)

Mitigating risk of aldosterone in diabetic kidney disease

Por Frimodt-Møller, Marie, Persson, Frederik, Rossing, Peter
Publicado no Curr Opin Nephrol Hypertens (2020)

Concomitant diabetes with atrial fibrillation and anticoagulation management considerations

Por Kreutz, Reinhold, Camm, A John, Rossing, Peter
Publicado no Eur Heart J Suppl (2020)

Fast renal decline to ESRD: an unrecognized feature of nephropathy in diabetes

Por Krolewski, Andrzej S., Skupien, Jan, Rossing, Peter, Warram, James H.
Publicado no Kidney Int (2017)

Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review

Por Persson, Frederik, Lindhardt, Morten, Rossing, Peter, Parving, Hans-Henrik
Publicado no J Renin Angiotensin Aldosterone Syst (2016)

Editorial: Novel Biomarkers for Type 2 Diabetes

Por Ahluwalia, Tarunveer S., Kilpeläinen, Tuomas O., Singh, Sandeep, Rossing, Peter
Publicado no Front Endocrinol (Lausanne) (2019)

Metformin and cardiorenal outcomes in diabetes: A reappraisal

Por Petrie, John R., Rossing, Peter R., Campbell, Ian W.
Publicado no Diabetes Obes Metab (2020)

Arterial Stiffness Is Associated With Cardiovascular, Renal, Retinal, and Autonomic Disease in Type 1 Diabetes

Por Theilade, Simone, Lajer, Maria, Persson, Frederik, Joergensen, Christel, Rossing, Peter
Publicado em 2013

Urinary Alpha- and Pi-Glutathione S-Transferases in Adult Patients with Type 1 Diabetes

Por von Scholten, Bernt Johan, Theilade, Simone, Lajer, Maria, Rossing, Peter
Publicado em 2014

Linking Kidney and Cardiovascular Complications in Diabetes—Impact on Prognostication and Treatment: The 2019 Edwin Bierman Award Lecture

Por Rossing, Peter, Persson, Frederik, Frimodt-Møller, Marie, Hansen, Tine Willum
Publicado no Diabetes (2021)

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria

Por Rathcke, Camilla Noelle, Persson, Frederik, Tarnow, Lise, Rossing, Peter, Vestergaard, Henrik
Publicado em 2009

Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With N...

Por Lajer, Maria, Jorsal, Anders, Tarnow, Lise, Parving, Hans-Henrik, Rossing, Peter
Publicado em 2010

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

Por Andersen, Sten, Mischak, Harald, Zürbig, Petra, Parving, Hans-Henrik, Rossing, Peter
Publicado em 2010

Vitamin D Levels, Microvascular Complications, and Mortality in Type 1 Diabetes

Por Joergensen, Christel, Hovind, Peter, Schmedes, Anne, Parving, Hans-Henrik, Rossing, Peter
Publicado em 2011

Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes: An Inception Cohort Study

Por Hovind, Peter, Rossing, Peter, Tarnow, Lise, Johnson, Richard J., Parving, Hans-Henrik
Publicado em 2009